Combination of radiotherapy and sorafenib in recurrent hepatocellular carcinoma: a case report

Yaoru Huang, Shang-Wen Chen, Chia-Chun Kuo, Jeng-Fong Chiou

Abstract


In patients with unresectable hepatocellular carcinoma (HCC), radiotherapy is considered for patients with a large tumor burden or tumors with portal vein tumor thrombosis, which is not indicated for operation or transarterial chemoembolization. Sorafenib has proved to be effective as a first-line treatment for locally advanced and metastatic HCC. Preclinical and clinical studies have shown the efficacy of the combined therapeutic effects of radiotherapy (RT) with sorafenib used either concurrently or sequentially. We presented a patient with multiple recurrent HCCs successfully treated with combined RT and sorafenib.

Full Text: PDF DOI: 10.5430/crcp.v1n2p155

Refbacks

  • There are currently no refbacks.


Case Reports in Clinical Pathology

ISSN 2331-2726 (Print)  ISSN 2331-2734(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the 'sciedu.ca' and ‘sciedupress.com’ domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'spam' or 'junk' folder.